- Home
- JOE vs PTGX Comparison
JOE vs PTGX Comparison
Compare JOE & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOE
- PTGX
- Stock Information
- Founded
- JOE 1936
- PTGX 2006
- Country
- JOE United States
- PTGX United States
- Employees
- JOE N/A
- PTGX N/A
- Industry
- JOE Homebuilding
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- JOE Real Estate
- PTGX Health Care
- Exchange
- JOE Nasdaq
- PTGX Nasdaq
- Market Cap
- JOE 3.4B
- PTGX 2.8B
- IPO Year
- JOE N/A
- PTGX 2016
- Fundamental
- Price
- JOE $50.53
- PTGX $46.46
- Analyst Decision
- JOE
- PTGX Strong Buy
- Analyst Count
- JOE 0
- PTGX 7
- Target Price
- JOE N/A
- PTGX $53.57
- AVG Volume (30 Days)
- JOE 278.0K
- PTGX 784.4K
- Earning Date
- JOE 10-23-2024
- PTGX 11-07-2024
- Dividend Yield
- JOE 1.11%
- PTGX N/A
- EPS Growth
- JOE N/A
- PTGX N/A
- EPS
- JOE 1.17
- PTGX 2.68
- Revenue
- JOE $385,141,000.00
- PTGX $323,795,000.00
- Revenue This Year
- JOE N/A
- PTGX $396.93
- Revenue Next Year
- JOE N/A
- PTGX N/A
- P/E Ratio
- JOE $43.24
- PTGX $17.31
- Revenue Growth
- JOE 5.76
- PTGX 125.73
- 52 Week Low
- JOE $49.36
- PTGX $16.80
- 52 Week High
- JOE $64.69
- PTGX $48.89
- Technical
- Relative Strength Index (RSI)
- JOE 35.36
- PTGX 57.05
- Support Level
- JOE $49.65
- PTGX $33.31
- Resistance Level
- JOE $50.72
- PTGX $48.86
- Average True Range (ATR)
- JOE 1.06
- PTGX 3.02
- MACD
- JOE 0.08
- PTGX -0.16
- Stochastic Oscillator
- JOE 25.05
- PTGX 84.57
About JOE St. Joe Company (The)
The St. Joe Co is a real estate development, asset management, and operating company and it has three operating segments; the Residential segment plans and develops residential communities and sells homesites to homebuilders or retail consumers, the Hospitality segment features a private membership club (the Watersound Club), hotel operations, food and beverage operations, golf courses, beach clubs, retail outlets, gulf-front vacation rentals, management services, marinas, and other entertainment assets, and Commercial segment include leasing of commercial property, multi-family, senior living, self-storage, and other assets and it also oversees the planning, development, entitlement, management, and sale of commercial and rural land holdings.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.